Case report: combination artemether-lumefantrine and haemolytic anaemia following a malarial attack

Stéphane Mérat1, Evelyne Lambert, Isabelle Vincenti-Rouquette

  • 1Department of Anaesthesiology, HIA du Valde Grâce, 74 Bd Port Royal, 75005 Paris, France. schmart@free.fr

Insights

A patient developed autoimmune haemolytic anaemia potentially linked to artemether-lumefantrine treatment. This rare complication, previously seen with similar drugs, highlights a possible association with increased blackwater fever cases.

Area of Science:

  • Pharmacology
  • Hematology
  • Tropical Medicine

Background:

  • Artemether-lumefantrine is a widely used antimalarial drug.
  • Autoimmune haemolytic anaemia (AIHA) is a rare but serious adverse effect associated with certain medications.
  • Aryl-amino-alcohol compounds have been implicated in previous cases of drug-induced AIHA.

Observation:

  • A case report details a patient admitted in Paris with AIHA in February 2001.
  • The patient's condition was likely caused by artemether-lumefantrine therapy.
  • This is the first documented instance of AIHA associated with lumefantrine specifically.

Findings:

  • The development of AIHA in a patient treated with artemether-lumefantrine.
  • The rarity of this complication with lumefantrine, despite its presence in similar drug classes.
  • A potential correlation between lumefantrine-induced AIHA and recent increases in blackwater fever episodes.

Implications:

  • Highlights the need for vigilance regarding potential hematological side effects of artemether-lumefantrine.
  • Suggests a possible link between drug-induced AIHA and blackwater fever, warranting further investigation.
  • Informs clinical practice regarding patient monitoring during antimalarial therapy, especially in regions with high malaria prevalence.

Related Concept Videos

Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...